Origin Therapeutics (CSE: ORIG) is an actively-managed investment issuer providing investors with diverse exposure to the psychedelic industry.
Our investment mandate is simple: focus on companies with an exemplary management team and exponential growth profile.
Company Details
- Founded
- -
- Address
- 505 Burrard St, Suite 1570,canada
- Industry
- Capital Markets
- NAICS
-
Securities, Commodity Contracts, and Other Financial Investments and Related ActivitiesSecurities and Commodity Contracts Intermediation and BrokerageSecurities BrokerageCommodity Contracts DealingCommodity Contracts Brokerage
- Website
- http://originpsychedelics.com
- Keywords
- Toronto.
- HQ
- Vancouver, British Columbia
Origin Therapeutics (Cse: Orig) Questions
Origin Therapeutics (Cse: Orig)'s website is http://originpsychedelics.com
Origin Therapeutics (Cse: Orig)'s LinkedIn profile is https://ca.linkedin.com/company/origin-therapeutics
Origin Therapeutics (Cse: Orig)'s industry is
Capital Markets
Origin Therapeutics (Cse: Orig)'s top competitors are
Dimensions,
Goldman Group,
Westockers,
Onchain,
Dealmaker,
The Flowr Group (Okanagan) Inc.,
Coinsquare,
Sent Coin,
Partners Value Split Corp,
Stafford.
Origin Therapeutics (Cse: Orig)'s categories are Capital Markets
Origin Therapeutics (Cse: Orig)'s founding year is 2020
